Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 1464 (Tablet) in Hyperlipemic Healthy Male Subjects

NCT02229773 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIBB 1464 MS low dose
DRUG: Placebo
DRUG: Pravastatin
DRUG: BIBB 1464 MS medium dose
DRUG: BIBB 1464 MS high dose

Sponsor

Boehringer Ingelheim